Want to join the conversation?
$MYL announced U.S. launch of Fenofibrate Tablets USP, 40 mg and 120 mg, which is generic of Santarus's Fenoglide. $MYL received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.